Cancer
Conditions
Interventions
Intervention group:The symptom management team provides specialized symptom management and intervention for cancer patients based on the ePRO system
Sponsors
Peking University Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Age =18 years; outpatient, diagnosed with advanced/late-stage cancer, currently receiving non-curative/palliative systemic anticancer treatment, including chemotherapy, targeted therapy, or immunotherapy; expected survival greater than 3 months, eligible for enrollment at any point during treatment, i.e., at any point in the treatment process or treatment cycle; able to independently complete ePRO system symptom reporting (via WeChat Mini Program) or with assistance from a family member; willing to participate in the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: Individuals with comorbid severe mental disorders (such as severe depression, schizophrenia, etc.) or cognitive impairment who are unable to cooperate with researchers; patients receiving curative treatment (such as adjuvant chemotherapy for breast cancer); hormonal therapy as the sole treatment modality (e.g., androgen deprivation therapy for prostate cancer); indolent/slow-progressing lymphomas; non-solid tumors, including leukemia, gliomas, etc.; those currently participating in other clinical trials; subjects for whom the researcher believes other conditions could potentially interfere with the effectiveness assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| EORTC QLQ-C30 physical functioning score;EORTC QLQ-C30 Global Quality of Life scale score;EORTC QLQ-C30 symptom burden score;Changes in EORTC QLQ-C30;THE PATIENTS HEALTH QUESTIONNAIRE-9 (PHQ-9);GENERAL ANXIETY DISORDER-7 (GAD-7);Completion status of chemotherapy;Emergency treatment frequency;Intervention compliance;Weekly eRPO report completion status; | — |
Countries
China
Contacts
Public ContactLILII TANG
Peking University Cancer Hospital
Outcome results
None listed